About Radiowave Therapy

Kanzius Therapy and Radiowave Therapy

Understanding radiowave therapy

Dr John Holt’s Therapy

Dr Holt developed a technique in the 1970’s which used radiowaves and their electromagnetic properties to stimulate cancer cells without affecting normal cells.
He used radiowaves in conjunction with either low dose radiation or with glycolytic metabolic inhibitors. In both cases the use of radiowaves was non thermal. He assessed that cancer cells responded to 434 MHz (he defined it as fluorescence) and he determined he could use this effect as the primary factor when combined with other specific methods in the destruction of cancer cells. A key benefit of the treatment is it is safe with minimal side effects.

The Radiowave Therapy Research Institute has been established to fund independent research into the use of radiowaves in the treatment of cancer – these studies are assessing the treatments of Dr Holt at the cellular level in the interests of confirming the science of the therapies.

Kanzius Therapy

The Kanzius story is interesting in that it is based on the use of radiowaves for their heating effect. The important factor seems to be the use of nanoparticles, which when attached to cancer cells can be the heated using radiowaves. This heating of the cancer cells ultimately kills the cancer. The stated benefit here is that normal cells would not be affected.

Comparing Dr Holt’s use of radiowaves and the Kanzius protocol:

In the main the treatments are completely different in the way they approach killing cancer, but there are some similarities:

  • Both the treatments use radiowaves
  • Both are not harmful to normal cells (ref Kanzius web site claim)
  • Both are safe treatments (ref Kanzius web site claim)
  • Both treatments are being extensively researched (in Dr Holt’s case, both the use of X-ray and glycolytic inhibitors)
  • Both treatments need more extensive and ongoing research
  • It will be some years before statistical evidencing of both treatments is completed

The differences:

The treatments are in fact quite different, but use transmitters and aerial arrays to deliver radiowave dosing:

  • Dr Holt claims a non thermal effect
  • Kanzius uses a thermal effect
  • The use of Dr Holt’s glycolytic inhibitors with radiowaves is currently available in Australia
  • Kanzius claims clinical trails to commence within about 3 years of Dec 08
  • Dr Holt’s treatment can be applied to non tumour cancers
  • Kanzius claims non tumour treatment methods will be developed

In General

Both treatments are very innovative and it will be some time before the medical communities will embrace these unconventional approaches. The Kanzius treatment could achieve very high kill rates and it is to be hoped that the current research findings lead quickly to clinical trials. It must be remembered that there are many types of cancer and each may need to be separately tested. Nevertheless, the innovation of the Kanzius approach offers exciting and unique possibilities.

Dr Holt showed great foresight in developing his therapies, but he used experiential learning and this means the formality of his historical evidencing does not satisfy current medical research criteria. This has meant a return to the laboratories and it means that the only treatment available is that which Dr Holt practiced at the time of his retirement. The identification of when and how this method works best, through a treatment outcomes analysis, is still some years away.

The use of Dr Holt’s method of radiowaves at 434 MHz with low dose radiation protocols is yet to complete the laboratory stage research. Nevertheless, many patients respond to Dr Holt’s current protocol and it cannot be discounted as an option for those with cancer to investigate further.